Bibliographic Info
GuidelineWHO consolidated guidelines on tuberculosis: module 4: treatment: drug-susceptible tuberculosis treatment.
Year of Publication2022
Issuing InstitutionWHO
Recommendation
Status
Maintained
Recommended in favor
Strong
Certainty of evidence
High
Wherever feasible, the optimal dosing frequency for new patients with pulmonary TB is daily throughout the course of therapy
Also Featured In
This recommendation also appears in the following guidelines:
Originally Developed
Guideline
Treatment of Tuberculosis: Guidelines
Year2010
Institution
Guideline
Guidelines for treatment of drug-susceptible tuberculosis and patient care
Year2017
InstitutionWorld Health Organization
Guideline
WHO consolidated guidelines on tuberculosis: module 4: treatment and care
Year2025
InstitutionWorld Health Organization